Vetology incorporates new search feature to softwareOctober 15, 2018Vetology Innovations has added new keyword search functionality to its artificial intelligence radiology software.
SPONSORED CONTENTA new way to offer multi-organ supportNEW Hill's Prescription Diet Multi-Organ offers therapeutic nutrition for pets that may have conflicting nutritional needs. + Learn More
Clinical award partnership aims to reduce student debt and provide jobsOctober 15, 2018Lincoln Memorial University-College of Veterinary Medicine (LMU-CVM) has announced an award partnership with Southern Veterinary Partners (SVP) aimed at reducing student debt and hiring quality veterinary associates.
They Ate What?! X-ray Contest 2018October 1, 2018Toys, tiles, and towels—and a large one at that! Animals eat all sorts of things, forcing their owners to make a mad dash to their veterinarian. Once again, our annual X-ray contest drew dozens of entries, each of them perplexing in their own way, and the next one more bizarre than the last. Choosing a winner was tough, but our panel of experts came through. The winner receives $500, courtesy of IDEXX Laboratories Inc., and a one-year subscription to its Web PACS, a picture archiving communications system valued at $2,400. Total retail value of the prize is $2,900. Check out the top rad, along with the honorable mentions.
Vetsource acquires VetSuccess to enhance data delivery, analyticsSeptember 10, 2018Vetsource, a Portland, Ore.-based technology-enabled healthcare services company, has acquired Toronto-based VetSuccess, a veterinary data analytics, machine learning, and business intelligence organization. Vetsource recently closed a $50 million round of investment led by Bain Capital Ventures. The company's services include home delivery of manufacturer-sourced medications and nutrition products, as well as the mobile-optimized ScriptRight ePrescribing tool that veterinarians use to write, review, and approve prescriptions from web-enabled devices. With the acquisition of VetSuccess, Vetsource will expand its customizable dashboards that give veterinary practices detailed performance data regarding the success of its home delivery program, according to the company. "Uniting VetSuccess with our services was a natural choice, as we share a common vision in providing essential solutions to veterinary practices and partnering with them in their success," said Kurt Green, president and CEO of Vetsource. "The addition of VetSuccess' leading-edge, data-focused technology will enable our customers to gain greater visibility into the health of their business, empowering them to make evidence-based decisions using their performance data in new and unparalleled ways."
Vetology automated AI heart evaluation tech available nationwideSeptember 7, 2018Vetology Innovations LLCÂ now offers automated heart evaluation tools to veterinarians as part of the company's artificial intelligence (AI) radiology software. In August, the San Diego-based company introduced its AI radiology software, designed to provide veterinary professionals with automated diagnostic analysis of patient radiographs. Individuals subscribing to the Vetology AI software suite will now gain full access to cardiac-specific tools, including automated heart-size evaluation and automated vertebral heart score calculations. These features work within the Vetology AI dashboard automatically when a clinic uploads an X-ray to the secure Vetology cloud. There, the software automatically evaluates an animal's heart size and the comparative size of the heart in relation to the vertebral body size. This process results in a Vetology AI heart evaluation report and vertebral heart score delivered to the veterinarian via email/fax in two minutes after the X-rays have fully uploaded. "The ability for a veterinarian to receive rapid heart analysis before they even begin evaluating a patient's radiograph is invaluable," said Seth Wallack, DVM, DACVR, founder of Vetology Innovations. "This technology leverages AI neural networks that are not yet available in human medicine. This new AI resource fulfills every attending doctor's hope …
20-plus clinics to participate in expanded osteosarcoma vaccine clinical trialSeptember 6, 2018Initial results of a pilot study for canine osteosarcoma vaccine are promising, prompting a larger study to test its safety and efficacy. Pharmaceutical company Aratana Therapeutics, which received conditional licensure for Live Listeria Vector (AT-014), has expanded its clinical trial to include more than two dozen veterinary oncology practice groups across the U.S. in order to receive full licensure. Conducted by the University of Pennsylvania School of Veterinary Medicine, the pilot study tested the immunotherapy treatment in 18 dogs. Those that received the vaccine lived more than twice as long as the historical, matched control group, with median survival times of 956 days compared to 423 days. The expanded clinical trial is designed to collect additional safety data for the vaccine in dogs that have undergone amputation of the affected limb and have already completed chemotherapy. If the treatment is found to be as safe and effective as it appeared in the initial clinical trial, Aratana will be given full licensure, allowing it to make the drug commercially available. Live Listeria Vector (AT-014) is created by removing harmful genes from the Listeria bacteria and then attaching markers of osteosarcoma cells. It is designed to supplement standard osteosarcoma treatment of amputation …
Boehringer Ingelheim receives new label claim for repro productAugust 29, 2018Boehringer Ingelheim announced that Cystorelin is now labeled for use in combination with Synchsure to synchronize estrous cycles to allow for fixed-time artificial insemination in lactating dairy cows and beef cows. When used together, the products can provide producers with shortened time to first service, increased estrus-detection efficiency, and improved first-service conception rate in their cattle. "Cystorelin and Synchsure deliver dependability and flexibility that can improve overall herd reproductive performance," Stephen Foulke, DVM, professional services veterinarian with Boehringer Ingelheim. "We're proud to help producers take the guesswork out of their breeding programs and to help their herd conceive and calve on schedule, saving them time and money." While many factors have a large impact on reproductive successes such as nutrition, cow comfort, heat abatement, dry cow management and more, Dr. Foulke said the best reproduction program is one that can get done consistently and correctly. "I recommend working closely with your herd veterinarian to determine your specific reproduction goals to implement the best synchronization program for your needs," he said. Visit SyncTheHerd.com to learn more about Cystorelin and Synchsure.
FDA, Health Canada issue pet product alert for King Bio due to microbial contaminationAugust 29, 2018The Food and Drug Administration and Health Canada are warning pet owners not to use products, including those labeled as homeopathic drug products, made by King Bio Inc. in Asheville, N.C., and labeled as Dr. King's, due to high levels of microbial contamination identified at the manufacturing site. King Bio has expanded a voluntary recall to include all water-based drug products marketed for animals. The FDA and Health Canada recommend consumers stop using and dispose of these products immediately. King Bio manufactures pet products for urinary incontinence and digestion relief. The full list of products is listed on the King Bio website. Pets who use these products could have an increased risk of serious infection that could require veterinary attention due to high levels of microbial contamination, according to the FDA. Pet owners who have purchased these products should contact their veterinarian if they have concerns or observe signs of an infection after use of these products. According to King Bio, after a recent FDA inspection, several microbial contaminants were found in its products, including Burkholderia multivorans, which is a strain of bacteria called Burkholderia cepacia complex that can cause illness …
Midmark Corp. unveils new corporate brand identityAugust 29, 2018Midmark Corp., a provider of veterinary, medical, and dental equipment, launched a new corporate brand identity that "captures the company's commitment to a better care experience and the growing value Midmark offers customers as they focus on improving clinical outcomes," said the company in a statement. The rebranding, which features a new website, logo, tagline (Designing better care), and more, "mirror[s] the transformation of Midmark from an equipment manufacturer into a clinical environmental design company," the company stated. "Care providers are always looking for new approaches, innovative technologies and proven solutions that can help enhance the patient and caregiver experience and improve the quality of care provided," said John Baumann, president and CEO. "Improving the experience between the patient and caregiver is at the heart of everything we do. Whether we are talking about a doctor's office, dental practice, or veterinary clinic, better care starts with a better-designed care environment, which leads to better outcomes." The Dayton, Ohio-based company, founded in 1915, has production and administrative offices in Versailles, Ohio; six other locations in the U.S.; and subsidiaries in India, Italy, and the U.K. Â
OSU enrolling dogs with mammary cancer for clinical trialAugust 29, 2018Oregon State University's Lois Bates Acheson Veterinary Teaching Hospital is now enrolling dogs with mammary cancer in a new clinical trial. Dog owners considering standard tumor removal surgery may be able to choose a new surgical procedure involving an intravenous injection of a cancer cell-illuminating nanoparticle compound that highlights exactly which tissue needs to be removed. After the mammary tumor is removed, the surrounding tissue is irradiated with an infrared laser that causes the nanoparticle compound to heat up, killing any remaining cancer cells. The compound, developed by researchers in the Oregon State University College of Pharmacy, has been found to effectively cure cancer in mice. The new procedure eventually may be most beneficial for treating tumors in challenging anatomic areas, such as the brain and spine, according to Milan Milovancev, DVM, DACVS-SA, an OSU associate professor of small animal surgery participating in the study. The Oregon State University Carlson College of Veterinary Medicine is a member of a national consortium of veterinary oncology centers, managed by the National Institutes of Health, with a focus on translational veterinary medicine. Owners who believe their pets may be good trial candidates can ask their veterinarian …
